Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5642 Journals

4484 Congresses

10100+ Unique Records

Acta Pharmacologica Sinica

Title Abbreviation

Acta Pharmacol Sin

ISSN

1671-4083

Electronic ISSN

1745-7254

Therapeutic Area

Chemistry, Molecular Medicine, Pharmacology

Readership

Chemists, Clinical Pharmacologists, Pharmacists, Pharmacologists

Scope

APS (Acta Pharmacologica Sinica) encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.

Sponsoring Association(s)

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Publisher Name

Nature Publishing Group - US

To see more details about Acta Pharmacologica Sinica, Subscribe Now!

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
	– Kait G Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
	– Michael K. Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
	- Weill Cornell Medical Library

Journals ● Congresses ● Associations

Privacy Policy ● Terms of Service ● Glossary ● OSS ● Contact Us